![]() |
市場調査レポート
商品コード
1433378
滅菌チューブ溶接機の世界市場:2023-2030年Global Sterile Tubing Welder Market 2023-2030 |
||||||
カスタマイズ可能
|
滅菌チューブ溶接機の世界市場:2023-2030年 |
出版日: 2023年12月26日
発行: Orion Market Research
ページ情報: 英文 105 Pages
納期: 2~3営業日
|
世界の滅菌チューブ溶接機市場は、予測期間(2023-2030年)にCAGR 5.6%で成長すると予測されています。滅菌チューブ溶接機の世界市場の需要を支えている主な要因としては、シングルユース技術の利用が増加していること、血液がん、貧血、血友病などの症例増加による血液および血液製剤の需要増加が市場成長をさらに押し上げると予測されていることなどが挙げられます。世界血友病連盟調査2022によると、血友病と確認された人の数は257,146人、血友病Aの人は208,957人、血友病Bの人は42,203人、血友病のタイプ不明またはタイプ未報告の人は5,986人でした。
2022年11月の「高齢者人口統計:A Portrait of Aging Americans」という記事によると、米国人口の16.3%にあたる5,410万人が65歳以上を含む高齢者です。シニア人口は2040年には22.0%、2060年には25.0%まで増加すると予想されています。一方、滅菌チューブ溶接機市場の成長を妨げるのは、チューブ溶接機に代わる新たな技術進歩の登場です。2021年9月、Dover傘下のColder Products Co.は新しい超小型滅菌コネクターを発売し、バイオ医薬品メーカーに少量閉鎖無菌プロセスで必要とされるチューブ溶接の代替手段を提供しました。MicroCNX(TM)シリーズコネクターは、小型アセンブリーでチューブを接続するシンプルで効率的な方法を提供するよう設計された業界初の無菌コネクターです。
最終用途の中では、病院サブセグメントが予測期間中に成長すると予測されています。病院では、患者のターンアラウンドタイムを短縮し、需要の増加に対応するために、洗練されたデバイスの採用が増加しています。複雑で高度な機器の使用により、病院では感染管理基準を満たすために無菌処理部門や機器の再評価が行われています。病院内の輸血委員会は、質の高い輸血と患者の安全のために無菌機器の使用を確実にすることが期待されています。世界保健機関(WHO)2023年によると、輸血を行っている病院の48.0%が輸血委員会を設置しており、その内訳は高所得国の病院が62.0%、上位中所得国が35.0%、下位中所得国が31%、低所得国が25.0%となっています。高所得国では、最も輸血頻度の高い患者グループは60歳以上で、全輸血の76.0%を占める。低所得国では、輸血の54.0%が5歳未満の小児です。このような統計から、予測期間中に滅菌チューブ溶接機の需要が増加すると予測されます。
滅菌チューブ溶接機の世界市場は、北米(米国、カナダ)、欧州(英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域)、アジア太平洋地域(インド、中国、日本、韓国、その他アジア地域)、世界のその他の地域(中東とアフリカ、中南米)を含む地域別にさらに細分化されています。なかでも欧州地域は、老人人口の増加、貧血の有病率の増加、医療費の増加により、欧州の滅菌チューブ溶接機市場を牽引し、予測期間中に成長すると予測されています。
北米は、予測期間中に滅菌チューブ溶接機市場で顕著なシェアを占めると予想されています。北米市場に燃料を供給する重要な要因は、北米全体で血友病の有病率が上昇していることであり、今後数年間は滅菌チューブ溶接機市場の成長にプラスの影響を与えると推定されます。米国疾病予防管理センター(CDC)によると、米国における血友病の推定有病率は、血友病Aは米国男性10万人当たり12人、血友病Bは米国男性10万人当たり3.7人です。さらに、米国出生児における血友病の推定罹患率は、血友病Aでは男性出生児5,617人当たり1人、血友病Bでは男性出生児19,238人当たり1人です。
Global Sterile Tubing Welder Market Size, Share & Trends Analysis Report by Mode (Manual and Automatic), By Application, (Biopharmaceutical, Blood Processing, Diagnostic Laboratories, and Others), and by End-use (Hospitals, Blood Centers, and Others), Forecast Period (2023-2030)
The global sterile tubing welder market is anticipated to grow at a CAGR of 5.6% during the forecast period (2023-2030). The primary factor supporting the demand for the global sterile tubing welder market globally includes the rising usage of single-use technologies and increasing demand for blood and blood products due to increasing cases of blood cancer, anemia, hemophilia, and more are anticipated to further boost the market growth. According to the World Federation of Hemophilia Survey 2022, number of people identified with Hemophilia were 257,146, people with hemophilia A were 208,957, people with hemophilia B were 42,203, and the people with hemophilia type unknown or type not reported 5,986.
Further, in November 2022, the article "Senior Population Statistics: A Portrait of Aging Americans", reported 54.1 million adults or 16.3% of the US population are seniors including aged 65 years and above. The senior population is expected to rise to 22.0% by 2040 and 25.0% by 2060. In contrast, entrance of a new technical advancement to replace the tub welder hinder the sterile tubing welder market growth. In September 2021, Colder Products Co., part of Dover, launched a new ultra-compact sterile connector providing biopharmaceutical manufacturers a much-required alternative to tube welding for their small-volume closed aseptic processes. MicroCNX™ Series Connectors are the industry's first aseptic connectors designed to provide a simple, efficient method of connecting tubing in small-format assemblies.
The global sterile tubing welder market is segmented by mode, application, and end-use. Based on the mode, the market is sub-segmented into manual and automatic. Based on the application, the market is sub-segmented into biopharmaceutical, blood processing, diagnostic laboratories, and others. Further, based on end-use, the market is sub-segmented into hospitals, blood centers, and others. Where others include research clinics. Among the mode, the automatic sub-segment is anticipated to hold the largest market share during the forecast period, owing to the reducing the need for manual labor and improving production throughput, and cost-effectiveness.
Among the end-use, hospitals sub-segment expected to grow over the forecast period. In hospitals, the growing adoption of sophisticated devices to reduce patient turnaround time and meet the increasing demand. The use of complex, sophisticated devices have, in turn, led hospitals to reevaluate sterile processing departments and equipment to meet the infection control standard. Transfusion committees in hospitals are anticipated to ensure the use of sterile equipment for quality transfusions and patient safety. According to World Health Organization 2023, 48.0% of the hospitals performing transfusions have a transfusion committee, with 62.0% of those in hospitals in high-income countries, 35.0% in upper-middle-income countries, 31 in lower-middle-income countries and 25.0% in low-income countries. In high-income countries, the most frequently transfused patient group is over 60 years of age, which accounts for up to 76.0% of all transfusions. In low-income countries, up to 54.0% of transfusions are for children under the age of 5 years. Such statistics project that the needs will increase the demand for sterile tubing welders over the forecast period.
The global sterile tubing welder market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, the European region is anticipated to grow over the forecast period, owing to the increasing geriatric population, increasing prevalence of anemia, the rising healthcare expenditure, driving the sterile tubing welder market in Europe.
North America is expected to hold a prominent share in the sterile tubing welder market during the forecast period. The significant factors fueling the North America market is the rising prevalence of hemophilia across the North America is estimated to positively impact the sterile tubing welder market growth in upcoming years. According to the Centers for Disease Control and Prevention (CDC), the estimated prevalence of hemophilia only in the US is 12 cases per 100,000 US males for hemophilia A and 3.7 cases per 100,000 US males for hemophilia B. Furthermore, the estimated incidence of hemophilia among US births is 1 birth/ 5,617 male births for hemophilia A in birth/ 19,238 male births for hemophilia B. Such conditions such as hemophilia A result from the absence or deficiency of Factor VIII (FVIII).
The major companies serving the global sterile tubing welder market include Cytiva (Life Sciences Solutions USA LLC), Genesis BPS, Sartorius AG, Terumo BCT, Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in May 2022, Colder Products Co., launched the new AseptiQuik G DC Series Connector designed to simplify closed-system liquid processing for biopharmaceutical manufacturers with the ability to connect and disconnect tubing aseptically using a single, sterile connection technology.